Electronically tracking purchases of pseudoephedrine, a cold medicine used in making methamphetamine, will not stop production or use of meth, according to a drug policy expert.
The Drug Enforcement Administration said this week that a new cold medicine must be kept behind pharmacy counters because it can be used to make methamphetamine. The medicine, Zephrex-D, contains a new form of pseudoephedrine that the drug’s maker says is difficult to use to make meth.
A new study in Kentucky links sales of cold medicine products containing pseudoephedrine, a key ingredient in methamphetamine, with meth lab busts. The study found each 13 grams of the decongestant sold per 100 residents was associated with one additional meth lab.
South Asian countries, including Iran and Pakistan, are quickly establishing themselves as a major force in the global methamphetamine market, the Associated Press reports.
A drug company says it has developed a formulation of the cold medicine pseudoephedrine that cannot be made into methamphetamine.
To reduce the number of methamphetamine labs in the state, Oklahoma prosecutors are asking lawmakers to make the tablet form of pseudoephedrine a prescription.
Iowa’s system to track and prevent sales of pseudoephedrine, a key ingredient of methamphetamine, has prevented more than 21,000 illegal purchases, a new report states.
The Director of Mississippi’s Bureau of Narcotics says the state’s law requiring prescriptions for the cold medicine pseudoephedrine, the key ingredient in methamphetamine, has reduced the number of meth labs in the state.
Kentucky is considering whether to require prescriptions for cold medicines containing pseudoephedrine, the key ingredient in methamphetamine.
Reproduction in whole or in part of this publication is strictly prohibited without prior consent. Photographic rights remain the property of Join Together and the Partnership for Drug-Free Kids. For reproduction inquiries, please e-mail email@example.com.